Your browser doesn't support javascript.
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management.
Matucci-Cerinic, Marco; Bruni, Cosimo; Allanore, Yannick; Clementi, Massimo; Dagna, Lorenzo; Damjanov, Nemanja S; de Paulis, Amato; Denton, Christopher P; Distler, Oliver; Fox, David; Furst, Daniel E; Khanna, Dinesh; Krieg, Thomas; Kuwana, Masataka; Lee, Eun Bong; Li, Mengtao; Pillai, Shiv; Wang, Yukai; Zeng, Xiaofeng; Taliani, Gloria.
  • Matucci-Cerinic M; Department of Experimental and Clinical Medicine, Division of Rheumatology, Università degli Studi di Firenze, Firenze, Toscana, Italy marco.matuccicerinic@unifi.it.
  • Bruni C; Department of Experimental and Clinical Medicine, Division of Rheumatology, Università degli Studi di Firenze, Firenze, Toscana, Italy.
  • Allanore Y; Rheumatology Department, Cochin Hospital, APHP, Paris Descartes University, Paris, France.
  • Clementi M; Unit of Microbiology and Virology, San Raffaele Hospital, Milano, Lombardia, Italy.
  • Dagna L; Unit of Microbiology and Virology, Università Vita Salute San Raffaele, Milano, Lombardia, Italy.
  • Damjanov NS; Vita-Salute San Raffaele University, Milan, Italy.
  • de Paulis A; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Denton CP; Rheumatology department, University of Belgrade School of Medicine, Belgrade, Serbia.
  • Distler O; Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, Italy.
  • Fox D; Department of Rheumatology, Royal Free Hospital, University College London, London, UK.
  • Furst DE; Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
  • Khanna D; Rheumatology department, University of Michigan, Ann Arbor, Michigan, USA.
  • Krieg T; Department of Experimental and Clinical Medicine, Division of Rheumatology, Università degli Studi di Firenze, Firenze, Toscana, Italy.
  • Kuwana M; Department of Medicine, Division of Rheumatology, University of California at Los Angeles, Los Angeles, California, USA.
  • Lee EB; University of Washington, Seattle, Washington DC, USA.
  • Li M; Rheumatology department, University of Michigan, Ann Arbor, Michigan, USA.
  • Pillai S; Translational Matrix Biology, Medical Faculty, Cologne, Germany.
  • Wang Y; Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
  • Zeng X; Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Taliani G; Rheumatology & Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Ann Rheum Dis ; 79(6): 724-726, 2020 06.
Article in English | MEDLINE | ID: covidwho-155085
ABSTRACT
Due to the frequent presence of interstitial lung disease and widespread use of immunosuppressive treatment, systemic sclerosis (SSc) patients may be considered at risk for a more severe disease course and higher mortality when they develop Severe Acute Respiratory Syndrome - Coronavirus - 2 (SARS-CoV-2) virus infection. Therefore, with World Scleroderma Foundation endorsement, experts from different specialties including rheumatology, virology and clinical immunology gathered virtually to answer to the main practical clinical questions regarding SARS-CoV-2 infection coming from both patients and physicians. This preliminary advice is aligned with other national and international recommendations, adapted for SSc patients.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Scleroderma, Systemic / Coronavirus Infections Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-217407

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Scleroderma, Systemic / Coronavirus Infections Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-217407